פנופיברט מגבירה את רמות הסולפטיד, שניכר כמועיל לטיפול בקורונה.
ממצאים עיקריים
Medical Hypotheses
Publication Date: יולי 21, 2020
Peer Reviewed: Yes
Publication Type: Original | Theoretical
DOI: https://www.doi.org/10.1016/j.mehy.2020.110127
Fenofibrate increases the amount of sulfatide which seems beneficial against Covid-19
Abstract
Fenofibrate, which is a PPAR-alfpha agonist, increases the level of sulfatide. In this letter we hypothesize on the background of various findings that this is beneficial against COVID-19. Fenofibrate has been used for decades against hypercholesterolemia and has no serious side effects. Therefore, a trial giving fenofibrate to patients with corona virus infection is recommended.